ABSTRACT
Because of the high risk of thrombosis, cancer patients often receive anticoagulants as prophylaxis or treatment. It has been suggested that antithrombotic agents influence cancer progression, but this is still a matter of debate, since it is unclear whether the aberrations in coagulation found in cancer patients are just an epiphenomenon or essential for the progression of cancer.
